Samalin Investment Counsel, LLC Genetic Technologies LTD Transaction History

Samalin Investment Counsel, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.01 $0 - $30	-3,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$0.0 - $0.02 $0 - $60	3,000 New	3,000 $0
Q1 2021 May 11, 2021	SELL	$0.0 - $0.01 $0 - $10	-1,000 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$0.0 - $0.0 $0 - $0	1,000 New	1,000 $3.6 Million

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.